News Medical on MSN6h
HIV drug access remains a major challenge despite promising trial resultsPromising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...
Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence Flynn ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback